EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA

Clinical trials for EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New weapon unleashed: immune therapy trial targets Tough-to-Treat cancers

Disease control Recruiting now

This study is testing a new drug called BI 764532 for adults with advanced small cell lung cancer or other neuroendocrine cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see if the drug can shrin…

Matched conditions: EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA

Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA

Get alerted when new EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA trials appear

New weapon unleashed: immune therapy trial targets Tough-to-Treat cancers